0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pravastatin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-34M6796
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Pravastatin Market Insights Forecast to 2028
BUY CHAPTERS

Pravastatin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-34M6796
Report
October 2024
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pravastatin - Market Size

The global market for Pravastatin was estimated to be worth US$ 547 million in 2023 and is forecast to a readjusted size of US$ 835 million by 2030 with a CAGR of 6.2% during the forecast period 2024-2030

Pravastatin - Market

Pravastatin - Market

Pravastatin (marketed as Pravachol or Selektine) is a member of the drug class of statins, used in combination with diet, exercise, and weight loss for lowering cholesterol and preventing cardiovascular disease.
North American market for Pravastatin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pravastatin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Pravastatin was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Pravastatin include Bristol-Myers Squibb, TEVA, SANDOZ, APOTEX, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Cipla Inc., Lupin Pharmaceuticals and Glenmark, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pravastatin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pravastatin by region & country, by Type, and by Application.
The Pravastatin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pravastatin.
Market Segmentation

Scope of Pravastatin - Market Report

Report Metric Details
Report Name Pravastatin - Market
Forecasted market size in 2030 US$ 835 million
CAGR 6.2%
Forecasted years 2024 - 2030
Segment by Type:
  • 10mg Tablet
  • 20mg Tablet
  • 40mg Tablet
  • 80mg Tablet
Segment by Application
  • Adults
  • Children
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol-Myers Squibb, TEVA, SANDOZ, APOTEX, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Cipla Inc., Lupin Pharmaceuticals, Glenmark, Mylan, Aurobindo Pharma, Accord Healthcare, Upsher-Smith Laboratories, Hisun, Jiangxi Boyaseehot Pharmaceutical, Shanghai Shyndec Pharmaceutical, Daiichi Sankyo, North China Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Pravastatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Pravastatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Pravastatin in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Pravastatin - Market size in 2030?

Ans: The Pravastatin - Market size in 2030 will be US$ 835 million.

Who are the main players in the Pravastatin - Market report?

Ans: The main players in the Pravastatin - Market are Bristol-Myers Squibb, TEVA, SANDOZ, APOTEX, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Cipla Inc., Lupin Pharmaceuticals, Glenmark, Mylan, Aurobindo Pharma, Accord Healthcare, Upsher-Smith Laboratories, Hisun, Jiangxi Boyaseehot Pharmaceutical, Shanghai Shyndec Pharmaceutical, Daiichi Sankyo, North China Pharmaceutical Group

What are the Application segmentation covered in the Pravastatin - Market report?

Ans: The Applications covered in the Pravastatin - Market report are Adults, Children

What are the Type segmentation covered in the Pravastatin - Market report?

Ans: The Types covered in the Pravastatin - Market report are 10mg Tablet, 20mg Tablet, 40mg Tablet, 80mg Tablet

1 Market Overview
1.1 Pravastatin Product Introduction
1.2 Global Pravastatin Market Size Forecast
1.2.1 Global Pravastatin Sales Value (2019-2030)
1.2.2 Global Pravastatin Sales Volume (2019-2030)
1.2.3 Global Pravastatin Sales Price (2019-2030)
1.3 Pravastatin Market Trends & Drivers
1.3.1 Pravastatin Industry Trends
1.3.2 Pravastatin Market Drivers & Opportunity
1.3.3 Pravastatin Market Challenges
1.3.4 Pravastatin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pravastatin Players Revenue Ranking (2023)
2.2 Global Pravastatin Revenue by Company (2019-2024)
2.3 Global Pravastatin Players Sales Volume Ranking (2023)
2.4 Global Pravastatin Sales Volume by Company Players (2019-2024)
2.5 Global Pravastatin Average Price by Company (2019-2024)
2.6 Key Manufacturers Pravastatin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Pravastatin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pravastatin
2.9 Pravastatin Market Competitive Analysis
2.9.1 Pravastatin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Pravastatin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pravastatin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 10mg Tablet
3.1.2 20mg Tablet
3.1.3 40mg Tablet
3.1.4 80mg Tablet
3.2 Global Pravastatin Sales Value by Type
3.2.1 Global Pravastatin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pravastatin Sales Value, by Type (2019-2030)
3.2.3 Global Pravastatin Sales Value, by Type (%) (2019-2030)
3.3 Global Pravastatin Sales Volume by Type
3.3.1 Global Pravastatin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Pravastatin Sales Volume, by Type (2019-2030)
3.3.3 Global Pravastatin Sales Volume, by Type (%) (2019-2030)
3.4 Global Pravastatin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Pravastatin Sales Value by Application
4.2.1 Global Pravastatin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pravastatin Sales Value, by Application (2019-2030)
4.2.3 Global Pravastatin Sales Value, by Application (%) (2019-2030)
4.3 Global Pravastatin Sales Volume by Application
4.3.1 Global Pravastatin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Pravastatin Sales Volume, by Application (2019-2030)
4.3.3 Global Pravastatin Sales Volume, by Application (%) (2019-2030)
4.4 Global Pravastatin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Pravastatin Sales Value by Region
5.1.1 Global Pravastatin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pravastatin Sales Value by Region (2019-2024)
5.1.3 Global Pravastatin Sales Value by Region (2025-2030)
5.1.4 Global Pravastatin Sales Value by Region (%), (2019-2030)
5.2 Global Pravastatin Sales Volume by Region
5.2.1 Global Pravastatin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Pravastatin Sales Volume by Region (2019-2024)
5.2.3 Global Pravastatin Sales Volume by Region (2025-2030)
5.2.4 Global Pravastatin Sales Volume by Region (%), (2019-2030)
5.3 Global Pravastatin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Pravastatin Sales Value, 2019-2030
5.4.2 North America Pravastatin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Pravastatin Sales Value, 2019-2030
5.5.2 Europe Pravastatin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Pravastatin Sales Value, 2019-2030
5.6.2 Asia Pacific Pravastatin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Pravastatin Sales Value, 2019-2030
5.7.2 South America Pravastatin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pravastatin Sales Value, 2019-2030
5.8.2 Middle East & Africa Pravastatin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pravastatin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pravastatin Sales Value
6.2.1 Key Countries/Regions Pravastatin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Pravastatin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Pravastatin Sales Value, 2019-2030
6.3.2 United States Pravastatin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pravastatin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pravastatin Sales Value, 2019-2030
6.4.2 Europe Pravastatin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pravastatin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pravastatin Sales Value, 2019-2030
6.5.2 China Pravastatin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pravastatin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pravastatin Sales Value, 2019-2030
6.6.2 Japan Pravastatin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pravastatin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pravastatin Sales Value, 2019-2030
6.7.2 South Korea Pravastatin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pravastatin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pravastatin Sales Value, 2019-2030
6.8.2 Southeast Asia Pravastatin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pravastatin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pravastatin Sales Value, 2019-2030
6.9.2 India Pravastatin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pravastatin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Information
7.1.2 Bristol-Myers Squibb Introduction and Business Overview
7.1.3 Bristol-Myers Squibb Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bristol-Myers Squibb Pravastatin Product Offerings
7.1.5 Bristol-Myers Squibb Recent Development
7.2 TEVA
7.2.1 TEVA Company Information
7.2.2 TEVA Introduction and Business Overview
7.2.3 TEVA Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 TEVA Pravastatin Product Offerings
7.2.5 TEVA Recent Development
7.3 SANDOZ
7.3.1 SANDOZ Company Information
7.3.2 SANDOZ Introduction and Business Overview
7.3.3 SANDOZ Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 SANDOZ Pravastatin Product Offerings
7.3.5 SANDOZ Recent Development
7.4 APOTEX
7.4.1 APOTEX Company Information
7.4.2 APOTEX Introduction and Business Overview
7.4.3 APOTEX Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 APOTEX Pravastatin Product Offerings
7.4.5 APOTEX Recent Development
7.5 Dr. Reddy's Laboratories
7.5.1 Dr. Reddy's Laboratories Company Information
7.5.2 Dr. Reddy's Laboratories Introduction and Business Overview
7.5.3 Dr. Reddy's Laboratories Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Dr. Reddy's Laboratories Pravastatin Product Offerings
7.5.5 Dr. Reddy's Laboratories Recent Development
7.6 Zydus Pharmaceuticals
7.6.1 Zydus Pharmaceuticals Company Information
7.6.2 Zydus Pharmaceuticals Introduction and Business Overview
7.6.3 Zydus Pharmaceuticals Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Zydus Pharmaceuticals Pravastatin Product Offerings
7.6.5 Zydus Pharmaceuticals Recent Development
7.7 Cipla Inc.
7.7.1 Cipla Inc. Company Information
7.7.2 Cipla Inc. Introduction and Business Overview
7.7.3 Cipla Inc. Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Cipla Inc. Pravastatin Product Offerings
7.7.5 Cipla Inc. Recent Development
7.8 Lupin Pharmaceuticals
7.8.1 Lupin Pharmaceuticals Company Information
7.8.2 Lupin Pharmaceuticals Introduction and Business Overview
7.8.3 Lupin Pharmaceuticals Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Lupin Pharmaceuticals Pravastatin Product Offerings
7.8.5 Lupin Pharmaceuticals Recent Development
7.9 Glenmark
7.9.1 Glenmark Company Information
7.9.2 Glenmark Introduction and Business Overview
7.9.3 Glenmark Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Glenmark Pravastatin Product Offerings
7.9.5 Glenmark Recent Development
7.10 Mylan
7.10.1 Mylan Company Information
7.10.2 Mylan Introduction and Business Overview
7.10.3 Mylan Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Mylan Pravastatin Product Offerings
7.10.5 Mylan Recent Development
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Company Information
7.11.2 Aurobindo Pharma Introduction and Business Overview
7.11.3 Aurobindo Pharma Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Aurobindo Pharma Pravastatin Product Offerings
7.11.5 Aurobindo Pharma Recent Development
7.12 Accord Healthcare
7.12.1 Accord Healthcare Company Information
7.12.2 Accord Healthcare Introduction and Business Overview
7.12.3 Accord Healthcare Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Accord Healthcare Pravastatin Product Offerings
7.12.5 Accord Healthcare Recent Development
7.13 Upsher-Smith Laboratories
7.13.1 Upsher-Smith Laboratories Company Information
7.13.2 Upsher-Smith Laboratories Introduction and Business Overview
7.13.3 Upsher-Smith Laboratories Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Upsher-Smith Laboratories Pravastatin Product Offerings
7.13.5 Upsher-Smith Laboratories Recent Development
7.14 Hisun
7.14.1 Hisun Company Information
7.14.2 Hisun Introduction and Business Overview
7.14.3 Hisun Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Hisun Pravastatin Product Offerings
7.14.5 Hisun Recent Development
7.15 Jiangxi Boyaseehot Pharmaceutical
7.15.1 Jiangxi Boyaseehot Pharmaceutical Company Information
7.15.2 Jiangxi Boyaseehot Pharmaceutical Introduction and Business Overview
7.15.3 Jiangxi Boyaseehot Pharmaceutical Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Jiangxi Boyaseehot Pharmaceutical Pravastatin Product Offerings
7.15.5 Jiangxi Boyaseehot Pharmaceutical Recent Development
7.16 Shanghai Shyndec Pharmaceutical
7.16.1 Shanghai Shyndec Pharmaceutical Company Information
7.16.2 Shanghai Shyndec Pharmaceutical Introduction and Business Overview
7.16.3 Shanghai Shyndec Pharmaceutical Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Shanghai Shyndec Pharmaceutical Pravastatin Product Offerings
7.16.5 Shanghai Shyndec Pharmaceutical Recent Development
7.17 Daiichi Sankyo
7.17.1 Daiichi Sankyo Company Information
7.17.2 Daiichi Sankyo Introduction and Business Overview
7.17.3 Daiichi Sankyo Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Daiichi Sankyo Pravastatin Product Offerings
7.17.5 Daiichi Sankyo Recent Development
7.18 North China Pharmaceutical Group
7.18.1 North China Pharmaceutical Group Company Information
7.18.2 North China Pharmaceutical Group Introduction and Business Overview
7.18.3 North China Pharmaceutical Group Pravastatin Sales, Revenue and Gross Margin (2019-2024)
7.18.4 North China Pharmaceutical Group Pravastatin Product Offerings
7.18.5 North China Pharmaceutical Group Recent Development
8 Industry Chain Analysis
8.1 Pravastatin Industrial Chain
8.2 Pravastatin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pravastatin Sales Model
8.5.2 Sales Channel
8.5.3 Pravastatin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Pravastatin Market Trends
    Table 2. Pravastatin Market Drivers & Opportunity
    Table 3. Pravastatin Market Challenges
    Table 4. Pravastatin Market Restraints
    Table 5. Global Pravastatin Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Pravastatin Revenue Market Share by Company (2019-2024)
    Table 7. Global Pravastatin Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Pravastatin Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Pravastatin Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Pravastatin Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Pravastatin Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Pravastatin
    Table 13. Global Pravastatin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pravastatin as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Pravastatin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Pravastatin Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Pravastatin Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Pravastatin Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Pravastatin Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Pravastatin Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Pravastatin Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Pravastatin Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Pravastatin Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Pravastatin Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Pravastatin Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Pravastatin Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Pravastatin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Pravastatin Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Pravastatin Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Pravastatin Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Pravastatin Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Pravastatin Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Pravastatin Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Pravastatin Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Pravastatin Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Pravastatin Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Pravastatin Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Pravastatin Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Pravastatin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Pravastatin Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Pravastatin Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Pravastatin Sales Value by Region (2019-2024) & (%)
    Table 44. Global Pravastatin Sales Value by Region (2025-2030) & (%)
    Table 45. Global Pravastatin Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Pravastatin Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Pravastatin Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Pravastatin Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Pravastatin Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Pravastatin Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Pravastatin Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Pravastatin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Pravastatin Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Pravastatin Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Pravastatin Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Pravastatin Sales Volume, (2025-2030) & (K Units)
    Table 57. Bristol-Myers Squibb Company Information
    Table 58. Bristol-Myers Squibb Introduction and Business Overview
    Table 59. Bristol-Myers Squibb Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Bristol-Myers Squibb Pravastatin Product Offerings
    Table 61. Bristol-Myers Squibb Recent Development
    Table 62. TEVA Company Information
    Table 63. TEVA Introduction and Business Overview
    Table 64. TEVA Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. TEVA Pravastatin Product Offerings
    Table 66. TEVA Recent Development
    Table 67. SANDOZ Company Information
    Table 68. SANDOZ Introduction and Business Overview
    Table 69. SANDOZ Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. SANDOZ Pravastatin Product Offerings
    Table 71. SANDOZ Recent Development
    Table 72. APOTEX Company Information
    Table 73. APOTEX Introduction and Business Overview
    Table 74. APOTEX Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. APOTEX Pravastatin Product Offerings
    Table 76. APOTEX Recent Development
    Table 77. Dr. Reddy's Laboratories Company Information
    Table 78. Dr. Reddy's Laboratories Introduction and Business Overview
    Table 79. Dr. Reddy's Laboratories Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Dr. Reddy's Laboratories Pravastatin Product Offerings
    Table 81. Dr. Reddy's Laboratories Recent Development
    Table 82. Zydus Pharmaceuticals Company Information
    Table 83. Zydus Pharmaceuticals Introduction and Business Overview
    Table 84. Zydus Pharmaceuticals Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Zydus Pharmaceuticals Pravastatin Product Offerings
    Table 86. Zydus Pharmaceuticals Recent Development
    Table 87. Cipla Inc. Company Information
    Table 88. Cipla Inc. Introduction and Business Overview
    Table 89. Cipla Inc. Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Cipla Inc. Pravastatin Product Offerings
    Table 91. Cipla Inc. Recent Development
    Table 92. Lupin Pharmaceuticals Company Information
    Table 93. Lupin Pharmaceuticals Introduction and Business Overview
    Table 94. Lupin Pharmaceuticals Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Lupin Pharmaceuticals Pravastatin Product Offerings
    Table 96. Lupin Pharmaceuticals Recent Development
    Table 97. Glenmark Company Information
    Table 98. Glenmark Introduction and Business Overview
    Table 99. Glenmark Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Glenmark Pravastatin Product Offerings
    Table 101. Glenmark Recent Development
    Table 102. Mylan Company Information
    Table 103. Mylan Introduction and Business Overview
    Table 104. Mylan Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Mylan Pravastatin Product Offerings
    Table 106. Mylan Recent Development
    Table 107. Aurobindo Pharma Company Information
    Table 108. Aurobindo Pharma Introduction and Business Overview
    Table 109. Aurobindo Pharma Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Aurobindo Pharma Pravastatin Product Offerings
    Table 111. Aurobindo Pharma Recent Development
    Table 112. Accord Healthcare Company Information
    Table 113. Accord Healthcare Introduction and Business Overview
    Table 114. Accord Healthcare Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Accord Healthcare Pravastatin Product Offerings
    Table 116. Accord Healthcare Recent Development
    Table 117. Upsher-Smith Laboratories Company Information
    Table 118. Upsher-Smith Laboratories Introduction and Business Overview
    Table 119. Upsher-Smith Laboratories Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Upsher-Smith Laboratories Pravastatin Product Offerings
    Table 121. Upsher-Smith Laboratories Recent Development
    Table 122. Hisun Company Information
    Table 123. Hisun Introduction and Business Overview
    Table 124. Hisun Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Hisun Pravastatin Product Offerings
    Table 126. Hisun Recent Development
    Table 127. Jiangxi Boyaseehot Pharmaceutical Company Information
    Table 128. Jiangxi Boyaseehot Pharmaceutical Introduction and Business Overview
    Table 129. Jiangxi Boyaseehot Pharmaceutical Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Jiangxi Boyaseehot Pharmaceutical Pravastatin Product Offerings
    Table 131. Jiangxi Boyaseehot Pharmaceutical Recent Development
    Table 132. Shanghai Shyndec Pharmaceutical Company Information
    Table 133. Shanghai Shyndec Pharmaceutical Introduction and Business Overview
    Table 134. Shanghai Shyndec Pharmaceutical Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Shanghai Shyndec Pharmaceutical Pravastatin Product Offerings
    Table 136. Shanghai Shyndec Pharmaceutical Recent Development
    Table 137. Daiichi Sankyo Company Information
    Table 138. Daiichi Sankyo Introduction and Business Overview
    Table 139. Daiichi Sankyo Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 140. Daiichi Sankyo Pravastatin Product Offerings
    Table 141. Daiichi Sankyo Recent Development
    Table 142. North China Pharmaceutical Group Company Information
    Table 143. North China Pharmaceutical Group Introduction and Business Overview
    Table 144. North China Pharmaceutical Group Pravastatin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 145. North China Pharmaceutical Group Pravastatin Product Offerings
    Table 146. North China Pharmaceutical Group Recent Development
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Pravastatin Downstream Customers
    Table 150. Pravastatin Distributors List
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pravastatin Product Picture
    Figure 2. Global Pravastatin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pravastatin Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Pravastatin Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Pravastatin Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Pravastatin Report Years Considered
    Figure 7. Global Pravastatin Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Pravastatin Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pravastatin Revenue in 2023
    Figure 10. Pravastatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 10mg Tablet Picture
    Figure 12. 20mg Tablet Picture
    Figure 13. 40mg Tablet Picture
    Figure 14. 80mg Tablet Picture
    Figure 15. Global Pravastatin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Pravastatin Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Pravastatin Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Pravastatin Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Pravastatin Price by Type (2019-2030) & (USD/Unit)
    Figure 20. Product Picture of Adults
    Figure 21. Product Picture of Children
    Figure 22. Global Pravastatin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Pravastatin Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Pravastatin Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Pravastatin Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Pravastatin Price by Application (2019-2030) & (USD/Unit)
    Figure 27. North America Pravastatin Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Pravastatin Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Pravastatin Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Pravastatin Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Pravastatin Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Pravastatin Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Pravastatin Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Pravastatin Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Pravastatin Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Pravastatin Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Pravastatin Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Pravastatin Sales Volume (%), (2019-2030)
    Figure 39. United States Pravastatin Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Pravastatin Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Pravastatin Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Pravastatin Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Pravastatin Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Pravastatin Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Pravastatin Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Pravastatin Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Pravastatin Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Pravastatin Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Pravastatin Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Pravastatin Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Pravastatin Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Pravastatin Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Pravastatin Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Pravastatin Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Pravastatin Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Pravastatin Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Pravastatin Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Pravastatin Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Pravastatin Sales Value by Application (%), 2023 VS 2030
    Figure 60. Pravastatin Industrial Chain
    Figure 61. Pravastatin Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Clindamycin Phosphate Topical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19S7015
Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Add to Cart

Candesartan Cilexetil Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-4B7213
Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Pravastatin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-34M6796
Mon Oct 07 00:00:00 UTC 2024

Add to Cart